In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on 99mTc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination-Reference-Cited by-同舟云学术

In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on 99mTc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination

Published:2020-12 Issue: Volume:22 Page:88-96
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Papathomas Thomas,Tzortzakakis Antonios^ORCID,Sun Na,Erlmeier Franziska,Feuchtinger Annette,Trpkov Kiril,Bazarova Alina,Arvanitis Alexandros,Wang Wanzhong,Bozoky Bela,Kokaraki Georgia,Axelsson Rimma,Walch Axel

Publisher

Elsevier BV

Subject

Urology

Reference33 articles.

1. Molecular classification of renal cell carcinoma and its implication in future clinical practice;Casuscelli;Kidney Cancer,2017

2. The Cancer Genome Atlas comprehensive molecular characterization of renal cell carcinoma;Ricketts;Cell Rep,2018

3. Molecular characterization and clinical relevance of metabolic expression subtypes in human cancers;Peng;Cell Rep,2018

4. Prospective evaluation of 99mTc-sestamibi SPECT/CT for the diagnosis of renal oncocytomas and hybrid oncocytic/chromophobe tumors;Gorin;Eur Urol,2016

5. Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression;Rowe;EJNMMI Res,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CARRoT: R-package for predictive modelling by means of regression, adjusted for multiple regularisation methods;PLOS ONE;2023-10-12

2. A pilot radiometabolomics integration study for the characterization of renal oncocytic neoplasia;Scientific Reports;2023-08-03

3. Machine Learning Integrating 99mTc Sestamibi SPECT/CT and Radiomics Data Achieves Optimal Characterization of Renal Oncocytic Tumors;Cancers;2023-07-09

4. ^99mTc-Sestamibi SPECT/CT and histopathological features of oncocytic renal neoplasia;Scandinavian Journal of Urology;2022-09-05

5. Low-grade oncocytic tumor (LOT)-a new renal entity ready for a prime time: An updated review;HISTOL HISTOPATHOL;2022